Trend Watch · Issue 012 · 23 March 2026
ARCHIVEA meta-analysis dropped. We read all 19 trials. Here is what they actually say.
Signed — Dr. Sundeep
Most beauty 'collagen drinks' (Hum, Vital, Crushed Tonic) deliver 5–10 g of collagen peptides identical to powder format, plus added sugar, flavours, and ₹ 200 per dose of bottling cost. The active ingredient works (see our Collagen Peptides brief) — the delivery format is a tax. Powder, mixed into coffee, gives the same endpoint at one-third the cost.
Bottom line
Same molecule. 3× the price. Buy the powder.
Exosomes are nano-vesicles released by cells; in vitro and animal data on wound healing are genuinely interesting. Human topical-cosmetic data is, at this point, very thin — no large RCTs, regulatory frameworks unclear, and the 'plant-derived exosomes' marketed by most clinics may not be exosomes at all by accepted molecular biology criteria. Charging ₹ 25,000 per facial for a poorly characterised ingredient is, kindly, premature.
Bottom line
Wait for the human RCTs. Save the money for sunscreen.
The skin-gut-microbiome axis is real and an active research area. The available human RCTs of oral probiotics (Lactobacillus rhamnosus, Bifidobacterium) for atopic dermatitis show modest improvement in children; adult skin-condition data is much thinner. The marketing has galloped well ahead of the literature. If you have eczema-prone children, worth a conversation with your derm. For adult 'glow' — the evidence does not yet support the spend.
Bottom line
Real research direction. Premature consumer market. Wait three years.